Sino Biological
Tracked across 3 events · 24 articles · First seen May 18, 2026 · Last active Aug 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Sino Biological launched its XPressMAX Cell-Free Protein Synthesis Kit, which is expected to accelerate antibody drug discovery and enhance its market position in recombinant technology.
May 18, 2026 · 8 articles
Tech
Impact: Sino Biological's gene synthesis and cell-free protein expression workflow, specifically its XPressMAX™ Cell-Free Protein Synthesis Kit, was utilized in a study published in Tata Communications by Tencent AI for Life Sciences Lab, validating AI-designed proteins. This highlights the company's role in advancing protein engineering and AI integration in life sciences.
May 28, 2026 · 10 articles
Business
Impact: Sino Biological, the parent company of SignalChem Biotech, advances its strategy of incorporating AI-enabled technologies across its global life science tools and services portfolio. The revenue impact is expected to be immaterial to its overall financial performance.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Sino Biological live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard